WINDY MCCARTHY: Open Payments
NPI 1699326918 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$724 in 44 payments from 10 companies in 2025. Trend: 2023 $278 · 2024 $621 · 2025 $724
Food & beverage: $724
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $305 |
| Janssen Biotech, Inc. | 14 | $192 |
| Gilead Sciences, Inc. | 4 | $71 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
| Lilly USA, LLC | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Novo Nordisk Inc | 1 | $17 |
Products named: TREMFYA, RINVOQ, LINZESS, SKYRIZI, CREON, MAVYRET, JOURNAVX, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
